Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
"A prospective, observational, non-randomized, European, multi-centerregistry, collecting REal-life information for the utilization of instantaneouswave-free ratio™ (iFR®) in Assessing coronary stenosis relevance in theMulti-vesseL disease patients population."	Volcano	Rejected	VOLCAO-iFR®	4	2014-CV-00	N/A
A Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men who are at High Risk for Poor Clinical Outcomes after Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men with Castration-Resistant Prostate Cancer and Men with Metastatic Prostate Cancer at Initial Diagnosis	Astellas	Rejected	-	4	ONC-MA1001	N/A
RETROSPECTIVE EPIDEMIOLOGY STUDY OF ALK REARRANGEMENT IN NON-SMALL CELL LUNG CANCER PATIENTS IN THE MIDDLE EAST & NORTH AFRICA	Pfizer	Rejected	-	4	A8081046	N/A
"(LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated "	Novartis	Completed	Ranibizumab 10mg/ml (Lucentis)	4	RFB002A2406	King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah), Prince Sultan Military Medical City (Riyadh)
An observational study to evaluate the effectiveness, safty and effect on health-related quality of life of treatment in routine practice (PERFORMS)	Novartis	Completed	Fingolimod	4	CFTY720D-MAX-TH-01	King Fahad Medical City (Riyadh), King Fahad Specialist Hospital (Dammam), King Faisal Specialist Hospital and Research Center (Jeddah)
An observational, prospective, open-label to assess effectiveness, safety and tolerability of once-yearly treatment with zoledronic acid in osteoporotic patients in a real-world setting (AZURE).	Novartis	Completed	Zoledronic acid	4	CZOL446H-MAX-SA-01	King Fahad University Hospital (Al-Khobar), King Khalid University Hospital (Riyadh)
A Phase 2, Open-label Study to Evaluate the Efficacy and Safety of KB195 in Subjects with a Urea Cycle Disorder with Inadequate Control on Standard of Care	Kaleido Biosciences	Ongoing	KB195	2	K020-218	King Khalid University Hospital (Riyadh), King Abdulaziz Medical City NG (Riyadh)
A two part seamless, open label, multi-center study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy.	Roche	Terminated	RO7034067	2	BP39056	King Faisal Specialist Hospital and Research Center (Riyadh)
AN OPEN-LABEL, SINGLE-ARM 4-YEAR STUDY TO EVALUATE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB TREATMENT IN PATIENTS WITH PROGRESSIVE MULTIPLE SCLEROSIS	Roche	Terminated	Ocrelizumab	3b	MN39159	King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh)
A SINGLE-ARM, MULTICENTER PHASE IIIB CLINICAL TRIAL TO EVALUATE THE SAFETY AND TOLERABILITY OF PROPHYLACTIC EMICIZUMAB IN HEMOPHILIA A PATIENTS WITH INHIBITORS	Roche	Ongoing	Emicizumab	3	MO39129	King Faisal Specialist Hospital and Research Center (Riyadh)